Invesco
PTX

Invesco’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Invesco’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,829
Closed -$19K – 3768
2016
Q1 		$19K Sell
1,829
-145
-7% -$2.88K ﹤0.01% 3695
2015
Q4 		$58K Buy
1,974
+80
+4% +$2.42K ﹤0.01% 3685
2015
Q3 		$60K Sell
1,894
-724
-28% -$34.6K ﹤0.01% 3721
2015
Q2 		$155K Sell
2,618
-15,939
-86% -$1.12M ﹤0.01% 3792
2015
Q1 		$1.98M Buy
18,557
+17,603
+1,845% +$1.68M ﹤0.01% 2607
2014
Q4 		$90K Sell
954
-22,520
-96% -$2.15M ﹤0.01% 3805
2014
Q3 		$1.8M Sell
23,474
-2,892
-11% -$228K ﹤0.01% 2599
2014
Q2 		$2.37M Sell
26,366
-16,986
-39% -$1.04M ﹤0.01% 2471
2014
Q1 		$2.32M Buy
+43,352
New +$1.43M ﹤0.01% 2472

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Invesco's PTX Position: Q2 2016 in Review

Invesco sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 1,829 shares — an estimated $19K sold.

Invesco first reported a position in PTX in Q1 2014 and held it in 9 quarters. The position peaked at $2.37M in Q2 2014. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • Invesco reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Invesco sold 1,829 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $19K.
  • Invesco first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2014 and held it in 9 quarters.
  • Invesco's Pernix Therapeutics Holdings, Inc. position peaked at $2.37M in Q2 2014.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Invesco's 13F filing for Q2 2016, filed 15 Aug 2016.